Vouchers vs. Prizes for Methadone Patients - 1
2 other identifiers
interventional
76
1 country
1
Brief Summary
The purpose of this study is to compare voucher-based contingency management (CM) procedures to a lower-cost CM system that provides opportunities to win prizes. Cocaine-dependent outpatients are randomly assigned to (a) standard treatment, (b) standard treatment plus voucher CM for abstinence, defined by negative breath and urinalysis test results, or (c) standard treatment plus prize CM for abstinence, defined by negative breath and urinalysis test results. Urine and breath samples are collected 3x/week during Weeks 1-3, 2x/week during Weeks 4-6 and 1x/week during Weeks 7-12. Follow-up interviews are conducted 1,3,6 and 9 months following intake during which substance use and psychosocial functioning are assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2003
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2003
CompletedFirst Submitted
Initial submission to the registry
November 3, 2005
CompletedFirst Posted
Study publicly available on registry
November 7, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2006
CompletedJanuary 12, 2017
May 1, 2008
2.4 years
November 3, 2005
January 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Drug use
baseline and each follow-up
Interventions
Eligibility Criteria
You may qualify if:
- age \> 18 years
- current DSM-IV diagnosis of cocaine dependence
- maintained on a stable dose of methadone for \>1 month
- willing to sign informed consent
- English speaking
You may not qualify if:
- serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, or substantial suicide risk) on the basis of history or medical examination
- dementia (\<23 on the Mini Mental State Exam)
- in recovery from pathological gambling as determined by DSM-IV criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Drug Abuse (NIDA)lead
- UConn Healthcollaborator
Study Sites (1)
University of Connecticut Health Center
Farmington, Connecticut, 06030 2103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nancy Petry, Ph.D.
UConn Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 3, 2005
First Posted
November 7, 2005
Study Start
August 1, 2003
Primary Completion
January 1, 2006
Study Completion
January 1, 2006
Last Updated
January 12, 2017
Record last verified: 2008-05